Why the study?
Do malignancy characteristics influence the risk of recurrent VTE in patients with cancer-associated thrombosis?
Population
Patients with cancer-associated venous thromboembolism from 10 observational studies
Comparison
Malignancy characteristics vs Different malignancy characteristics
Design
Systematic_review
Authors
Loading...
May warrant closer VTE surveillance or extended anticoagulation in metastatic cancer; confirms stage-specific recurrence risk and refines cancer-associated thrombosis stratification.
Do malignancy characteristics influence the risk of recurrent VTE in patients with cancer-associated thrombosis?
Metastatic malignancy, adenocarcinoma, and lung malignancy appear to confer a higher risk of VTE recurrence in patients with cancer-associated thrombosis compared to localized disease or other cancer types.
Louzada et al. (2011) studied this question.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: